Director Gregg Williams Deepens Conviction with Another $1M Vivani Medical Purchase
VANI sits 53% above its 52-week low of $0.923.
Summary
Director and 10% owner Gregg Williams bought another $1M in Vivani Medical stock, continuing a pattern of heavy insider accumulation amid positive clinical and partnership developments.
Key Events · Ownership and Investor Activity · VANI
-
Williams Buys $1M More Stock
Under a pre-existing August 2025 agreement, director and 10% owner Gregg Williams purchased 793,650 shares at $1.26 per share for a total of $999,999 on July 15, 2026.
-
Accumulation Pattern Continues
This is Williams' third open-market purchase in three months, totaling $4M, following $2M on May 19 and $1M on June 16, signaling strong insider conviction.
-
Post-Transaction Stake
Williams now holds 36,912,736 shares directly and indirectly, representing approximately 30% of the company's outstanding shares.
-
Positive Clinical and Partnership Backdrop
The purchase follows successful first-in-human trial results for NPM-139 and a Novo Nordisk evaluation agreement, both announced in recent weeks.
Analysis · VANI · Industrial Applications And Services
On July 15, 2026, director and 10% owner Gregg Williams acquired $999,999 worth of Vivani Medical common stock at $1.26 per share. This marks his third substantial open-market purchase in three months, following $2M on May 19 and $1M on June 16, bringing his total recent investment to $4M. The $1.26 price was set under a pre-existing agreement from August 2025, representing a discount to the current $1.41 market price. Williams now controls 36.9 million shares, reinforcing his conviction in the company's GLP-1 implant pipeline, which recently achieved positive clinical milestones and a Novo Nordisk evaluation agreement.
At the time of this filing, VANI was trading at $1.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $121.6M. The 52-week trading range was $0.92 to $1.92. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.